Steady-State Comparative Bioavailability Study in Patients Requiring Anti-Fungal Prophylaxis Comparing Twice a Day Dosing of Lozanoc (Mayne) Regardless of Food With Sporanox (Janssen) Under Fed Conditions
Phase of Trial: Phase IV
Latest Information Update: 21 Jul 2016
At a glance
- Drugs Itraconazole (Primary)
- Indications Mycoses
- Focus Pharmacokinetics
- Sponsors Mayne Pharma Group
- 21 Jul 2016 Last checked against ClinicalTrials.gov record.
- 28 Apr 2016 Planned End Date changed from 1 Jun 2016 to 1 Dec 2016.
- 28 Apr 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Nov 2016.